Answers are grounded in this paper and cite their sources.
Adjuvant development is driven by the need to improve immune responses to vaccine antigens without increasing side effects beyond an acceptable level. Adjuvant use in human vaccines has been both l...
No takes yet. Share an insight, caveat, or question.
Bengtsson et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: